Presentation TCT 2013 TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV... Presenter: Thierry Lefevre October 29, 2013
Presentation Efficient Evaluation for TAVR: What Do We Really Need? Presenter: John Webb October 29, 2013
Presentation TCT 2013 Intracoronary Infusion of Bone Marrow Mesenchymal Stem Cells in Acute Myocardial Infarction- A Critical Challenge for Dosage-Related Efficacy and Safety Presenter: Lian R. Gao October 29, 2013
Presentation TCT 2013 TCT-89. Percutaneous Leaflet Therapy of Severe Primary Mitral Regurgitation: Totality of Evidence From the EVEREST II Randomized, Continued Access, and High Risk Clinical... Presenter: Saibal Kar October 29, 2013
Presentation Alternative Approaches to Nonsurgical Mitral Repair Presenter: Mark Reisman October 29, 2013
Presentation TCT 2013 Is There Still a Role for Alternative Access in TAVR (Transapical, Other)? Presenter: Thomas Walther October 29, 2013
Presentation TCT 2013 Case Presentations: The Issue: Introducing Two Cases That Might Invoke Different Revascularization Approaches (Multivessel and Left Main Disease) Presenter: Vasim Farooq October 29, 2013
Presentation TCT 2013 TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled Presenter: Robert Whitbourn October 29, 2013
Presentation TCT 2013 Appropriateness Use Criteria Recommendations for SIHD: Strengths, Limitations, and Evolution of Terminology and Process Presenter: Manesh Patel October 29, 2013